Evidence map›Paper›PMID 31910709›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia.

Naohide Kurita, Kazuo Yamashiro, Takuma Kuroki, Ryota Tanaka, Takao Urabe, Yuji Ueno, Nobukazu Miyamoto, Masashi Takanashi, Hideki Shimura, Toshiki Inaba and 7 more

Abstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Targeting the intestinal TLR4-GABAJournal of neuroinflammation · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Naohide KuritaDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Kazuo YamashiroDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Takuma KurokiDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Ryota TanakaDivision of Neurology, Department of Internal Medicine, Jichi Medical University, Tochigi Japan.
Takao UrabeDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Yuji UenoDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.ORCID 0000-0002-8617-3695
Nobukazu MiyamotoDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Masashi TakanashiDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Hideki ShimuraDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Toshiki InabaDepartment of Neurology, Juntendo University Urayasu Hospital, Chiba, Japan.
Yuichiro YamashiroProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Koji NomotoProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Satoshi MatsumotoProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takuya TakahashiProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-9998-2611
Hirokazu TsujiProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takashi AsaharaProbiotics Research Laboratory, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nobutaka HattoriDepartment of Neurology, Juntendo University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria and a potent inflammatory stimulus for the innate immune response via toll-like receptor (TLR) 4 activation. Type 2 diabetes is associated with changes in gut microbiota and impaired intestinal barrier functions, leading to translocation of microbiota-derived LPS into the circulatory system, a condition referred to as metabolic endotoxemia. We investigated the effects of metabolic endotoxemia after experimental stroke with transient middle cerebral artery occlusion (MCAO) in a murine model of type 2 diabetes (

Indexed as

Administration, OralAnimalsAnti-Bacterial AgentsBrain IschemiaCase-Control StudiesCytokinesDiabetes Mellitus, Type 2EndotoxemiaGastrointestinal MicrobiomeGram-Negative BacteriaImmunity, InnateInfarction, Middle Cerebral ArteryLipopolysaccharidesMaleMiceModels, AnimalAnti-Bacterial AgentsCytokinesLipopolysaccharidesPolymyxin BTLR4 protein, humanToll-Like Receptor 4Gut microbiotalipopolysaccharidemetabolic endotoxemiastroketype 2 diabetes

Identifiers

PMID31910709
PMCPMC7820690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.